CheckMan Stock Market Overview

Realty Income offers steady monthly net-lease income, while Prologis leans on record leasing, development value creation and data center/energy growth.

RIVN faces an NHTSA probe into nearly 115K R1S and R1T EVs after reports of rear toe link failures causing swerving and a crash.

KMI, MPLX and WMB may offer steadier, fee-based midstream cash flows as Iran-war turmoil whipsaws WTI, backed by long-term shipper contracts.

GECC, PLGO and PVH made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 29, 2026.

SNDK's QLC Stargate is set for Q4 FY26 shipments, targeting AI data-center storage demand and adding a new growth path beyond TLC SSDs.

Eli Lilly hits a record high after CVS expands coverage for Foundayo and Zepbound, boosting obesity drug access and raising the stakes in its rivalry with NVO.

I rate Mobileye (MBLY) a buy due to its superior technology, broad physical AI applications, positive FCF, and reasonable valuation versus Ouster (OUST). MBLY's mobility-focused sensors and 25 years of experience position it for long-term demand and higher returns as AV and AI adoption accelerates. MBLY's growth inflects meaningfully in 2028+ when Chauffeur and Drive systems are deployed in robotaxis, potentially driving a valuation re-rating.

New York, New York--(Newsfile Corp. - May 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Upstart Holdings, Inc. (NASDAQ: UPST) between May 14, 2025 and November 4, 2025, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline. SO WHAT: If you purchased Upstart securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Subscribers to Schaeffer's Weekend Trader options recommendation service received this TWLO commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters.

New York, New York--(Newsfile Corp. - May 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gossamer Bio, Inc. (NASDAQ: GOSS) between June 16, 2025 and February 20, 2026, inclusive (the "Class Period"), of the important June 1, 2026 lead plaintiff deadline. SO WHAT: If you purchased Gossamer securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.